1. Home
  2. RETO vs MBAI Comparison

RETO vs MBAI Comparison

Compare RETO & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RETO

ReTo Eco-Solutions Inc.

HOLD

Current Price

$2.68

Market Cap

10.0M

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.16

Market Cap

10.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RETO
MBAI
Founded
1999
2004
Country
China
Israel
Employees
N/A
85
Industry
Multi-Sector Companies
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.3M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
RETO
MBAI
Price
$2.68
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
52.9K
62.3K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.06
52 Week High
$4.66
$3.92

Technical Indicators

Market Signals
Indicator
RETO
MBAI
Relative Strength Index (RSI) 58.54 36.46
Support Level $2.49 N/A
Resistance Level $2.80 $2.02
Average True Range (ATR) 0.18 0.11
MACD -0.06 -0.01
Stochastic Oscillator 59.32 20.17

Price Performance

Historical Comparison
RETO
MBAI

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Equipment and technical service segment, and Craft beer segment. The company earns its revenue from the Equipment and technical service segment. Geographically, it derives a majority of its revenue from China.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: